Telsey Advisory Group Cuts Albertsons Companies (NYSE:ACI) Price Target to $21.00

Albertsons Companies (NYSE:ACI) had its target price lowered by equities research analysts at Telsey Advisory Group from $27.25 to $21.00 in a note issued to investors on Thursday,Benzinga reports. The firm presently has a “market perform” rating on the stock. Telsey Advisory Group’s price objective points to a potential upside of 7.75% from the stock’s previous close.

ACI has been the topic of a number of other research reports. Melius Research upgraded shares of Albertsons Companies from a “hold” rating to a “buy” rating and set a $24.00 target price on the stock in a research note on Monday, October 21st. Evercore ISI lifted their target price on Albertsons Companies from $18.00 to $19.00 and gave the stock an “in-line” rating in a research report on Tuesday, December 3rd. Tigress Financial reissued a “buy” rating and set a $27.00 price target on shares of Albertsons Companies in a research report on Monday, October 21st. Wells Fargo & Company reiterated a “market perform” rating on shares of Albertsons Companies in a research note on Friday, October 18th. Finally, Morgan Stanley reduced their price target on shares of Albertsons Companies from $24.00 to $19.00 and set an “equal weight” rating on the stock in a research report on Wednesday. Six analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $22.09.

Albertsons Companies Trading Up 1.9 %

NYSE:ACI opened at $19.49 on Thursday. The stock has a market cap of $11.29 billion, a price-to-earnings ratio of 11.40, a price-to-earnings-growth ratio of 1.07 and a beta of 0.51. Albertsons Companies has a one year low of $17.00 and a one year high of $23.47. The company has a debt-to-equity ratio of 2.58, a quick ratio of 0.22 and a current ratio of 0.90. The business’s 50-day simple moving average is $18.87 and its 200 day simple moving average is $19.39.

Albertsons Companies (NYSE:ACI) last released its earnings results on Tuesday, October 15th. The company reported $0.51 EPS for the quarter, beating the consensus estimate of $0.48 by $0.03. The company had revenue of $18.55 billion during the quarter, compared to analysts’ expectations of $18.47 billion. Albertsons Companies had a return on equity of 49.50% and a net margin of 1.25%. The business’s revenue was up 1.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.60 EPS. As a group, sell-side analysts predict that Albertsons Companies will post 2.13 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in ACI. Signaturefd LLC boosted its stake in shares of Albertsons Companies by 108.4% during the 2nd quarter. Signaturefd LLC now owns 2,365 shares of the company’s stock worth $47,000 after acquiring an additional 1,230 shares in the last quarter. Blue Trust Inc. boosted its position in shares of Albertsons Companies by 2,948.4% in the 2nd quarter. Blue Trust Inc. now owns 2,896 shares of the company’s stock valued at $62,000 after purchasing an additional 2,801 shares during the period. Intact Investment Management Inc. purchased a new position in Albertsons Companies in the 2nd quarter worth about $126,000. Acadian Asset Management LLC acquired a new stake in Albertsons Companies during the 2nd quarter worth about $150,000. Finally, Headlands Technologies LLC lifted its stake in Albertsons Companies by 2,243.9% during the second quarter. Headlands Technologies LLC now owns 8,977 shares of the company’s stock valued at $177,000 after buying an additional 8,594 shares in the last quarter. Institutional investors and hedge funds own 71.35% of the company’s stock.

Albertsons Companies Company Profile

Albertsons Companies, Inc, through its subsidiaries, engages in the operation of food and drug stores in the United States. The company’s food and drug retail stores offer grocery products, general merchandise, health and beauty care products, pharmacy, fuel, and other items and services. It also manufactures and processes food products for sale in stores.